16 - 18 April 2007, Victoria Park Plaza, London, United Kingdom
Making connections.
Register   |    Brochure   |    Sponsor   |    Email a friend   |    Add to diary



Calendar of Events
bioLOGIC Europe 2008 ~ Geneva
World Drug Safety Congress Europe ~ London
European BioPharm Scale-Up Congress 2008 ~ Geneva
Exploratory Clinical Development World Americas ~ Philadelphia
World Vaccine Congress Lyon 2008 ~ Lyon
World Vaccine Congress Australia 2008 ~ Sydney
Oncology Drug Development World Europe 2008 ~ London

More events >

Scientific advisory board

We are delighted to announce our official Scientific Advisory Board for Life Science Alliances World
 
We believe that the best conference agendas are validated by well-respected industry figures. An event can not meet the needs of the biopharmaceutical industry if there is no input from the industry. Our advisory panel comprises thought leaders from GlaxoSmithKline, the Wellcome Trust and Taylor Wessing. The panel has had key input into our agenda content to ensure both quality and relevance.
 
Scientific board members include:
  • Dr Malcolm Skingle, Director of Academic Liaison, GlaxoSmithKline
  • Dr Richard Seabrook,  Founding Member of the Technology Transfer Division, The Wellcome Trust
  • Dr Tony Bradshaw, Director, bioProcessUK
  • Daniel Pavin, Partner, Taylor Wessing
There are still opportunities for you to join our official scientific advisory board. To apply please email louise.wren@terrapinn.com
 
Dr Malcolm Skingle is Director of Academic Liaison at GlaxoSmithKline. For more than a decade he has managed Academic Liaison at GSK. This role involves close liaison with several groups outside the Company such as Government Departments, Research and Funding Councils, Small Biotechnology Companies and other science-driven organisations.  He sits on many external bodies including the Biotechnology and Biological Sciences Research Council Strategy Board, the Confederation of British Industries academic liaison group and several UK University Department advisory groups.
 


Dr
Richard Seabrook is a founding member of the Technology Transfer Division, The Wellcome Trust, where he is Head of Business Development. He is also technology transfer advisor to the Wellcome Trust Sanger Institute and Genome Research Limited. Richard has extensive experience with early-stage funding of life science technologies, investment and licensing transactions, intellectual property management board, SAB and government agency advisory roles.
 


Dr Tony Bradshaw
is Director of bioProcessUK, a knowledge transfer network funded through the DTI Technology Programme, and managed by the BioIndustry Association. He has been involved in biotechnology business development for 16 years working for British Sugar, University College London and in executive search for Ruston Poole and Harvey Nash. He was appointed to the Board of UK BioIndustry Association for the period 1999-2001.
 


Taylor Wessing
's top ranked Life Sciences and Healthcare Group is a multi-disciplinary group combining Taylor Wessing’s market leading intellectual property and venture capital lawyers with specialists from our highly rated international corporate, corporate finance, employment and real estate practices. The Group represents businesses, academic institutions and individuals based in the UK, US and all over the world. Taylor Wessing has offices in the UK (London and Cambridge), Germany, France and Belgium, associated offices in Alicante, China and Dubai and extensive international connections.

Event partner
Luncheon sponsor
Organised by